The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.
Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...
Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
The Oklahoma Medical Research Foundation has received a $3 million grant to study Parkinson's disease, potentially leading to ...
It can be used treat essential tremor, Parkinson’s disease, epilepsy, and neuropathic pain through sound waves ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
offering a new therapeutic ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results